Nippon Shokubai (TSE:4114) Stock Jumps As Profit Margin Momentum Builds

Nippon Shokubai stock went into the Q1 2027 print with a strong tailwind, up 17.5% over the past month, and the latest numbers give investors more to chew on than a simple relief rally. Basic earnings per share for the quarter came in at ¥70.23 on revenue of ¥121,318m, which puts fresh focus on whether the recent rebound is grounded in improving profitability or just sentiment.

The longer horizon matters here. Trailing twelve month earnings rose 32% and the P/E of 15.9x still sits below the peer average. This puts the spotlight on how much of that multi year earnings story is already reflected in the current price.

Is Nippon Shokubai trading at a genuine discount, or is this just a short term rerating after a strong earnings run? Compare the current share price to our full valuation analysis for Nippon Shokubai

Q1 2027 Earnings Summary

• Revenue (Q1 2027 vs Q1 2026): ¥121,318m vs. ¥101,247m (up about 19.8%)
• Net Income (Excl. Extra Items, Q1 2027 vs Q1 2026): ¥10,378m vs. ¥4,434m (up about 134.1%)
• Basic EPS (Q1 2027 vs Q1 2026): ¥70.23 vs. ¥29.26 (up about 139.9%)
• Trailing 12-month Net Profit Margin (TTM vs prior TTM): 5.4% vs. 4.2% (improved profitability on a full year view)

Prefer clean charts over staring at rows of earnings figures? Get a full visual picture of Nippon Shokubai's valuation story in an easy dashboard via our company report for Nippon Shokubai.

Nippon Shokubai: Earnings Momentum Backs Constructive View

For investors leaning positive on Nippon Shokubai, the latest quarter gives the core story some real support. Revenue of ¥121,318m and basic EPS of ¥70.23 both sit well ahead of the prior year, and trailing 12‑month net profit margin has moved to 5.4% from 4.2%. That pattern fits a narrative of a diversified chemical group that is converting a broad product mix into better earnings quality, rather than just riding price moves in a single commodity line.

Short Term Beat Does Not Erase Cyclical Questions

The strong Q1 numbers and firmer margin ease near term worries about pressure on Nippon Shokubai from feedstock costs or weak end markets. Net income excluding extra items reached ¥10,378m compared with ¥4,434m a year earlier, which points to healthier underlying operations. Even so, the company still sits in cyclical chemicals. Investors who worry about swings in global industrial demand or future regulatory costs will see this as a better starting point, not a resolved risk.

Reveal where the surface looks calm, but the models start to disagree on Nippon Shokubai's next few years. Access the full revenue, margin and EPS timeline in the street's analyst estimates for Nippon Shokubai.

Take Control Of Your Next Move

If the latest Q1 2027 results have put Nippon Shokubai on your radar, register for free with Simply Wall St and add it to a Watchlist so you can track the share price against fair value and wait for a setup that suits your plan. Once you hold the stock, use the Portfolio Command Center to cut through noise and focus on the key fundamental and valuation updates that matter to your thesis. For a broader perspective on Nippon Shokubai and comparable stocks, tap into the Community to see how other investors are thinking about risks and opportunities. By spotting potential catalysts and warning signs early, you put yourself in a stronger position to stay ahead of the market.

Seeking Alternatives Beyond Nippon Shokubai?

Fresh ideas can move quickly. Some stocks build breakout momentum while they are still under the radar for now. Before the best entry points get caught, act now.

• Spot companies building steady momentum with resilient balance sheets and cash flows through our curated list of solid balance sheet and fundamentals stocks (40 results). Get a shortlist before others start paying attention.
• Zero in on resilient opportunities where downside risk scores stay tight using the hand picked 56 resilient stocks with low risk scores. Position yourself before caution turns into broad buying.
• Ride early breakout trends in proven producers using the focused 30 elite gold producer stocks. Do the work now while these ideas remain under the radar for most investors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com